Agilent Technologies, Inc.

Industrials
Biotechnology: Laboratory Analytical Instruments
www.agilent.com

Earnings Score
Moat Score
Safety Score
Final Score

Market Cap $29.86B
PE 24
Debt $3.36B
Cash $1.47B
EV $31.75B
FCF $1.31B

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	$1.26B
EBIT	$1.49B
ROE	21%
ROA	13%
FCF	$1.31B
Equity	$6.03B
Growth Stability	61%
PE	23.72
PEG	1.7
PB	4.95
P/FCF	22.76
P/S	4.57
Price/Cash	0.05
Debt/Equity	0.56
Debt/FCF	2.56
Net Margins	19%
Gross Margins	54%
Op. Margins	23%
Earnings CAGR	17%
Sales Growth YoY	1%
Sales Growth QoQ	-1%
Sales CAGR	7%
FCF CAGR	10%
Equity CAGR	4%
Earnings Stability	0.56
Earnings Growth YoY	-9%
Earnings Growth QoQ	-9%
Earnings CAGR 5Y	14%

Sales CAGR 5Y	5%
FCF CAGR 5Y	13%
Equity CAGR 5Y	6%
Earnings CAGR 3Y	-1%
Sales CAGR 3Y	-1%
FCF CAGR 3Y	15%
Equity CAGR 3Y	7%
Market Cap	$29.86B
Revenue	$6.53B
Dividend Yield	1%
Payout Ratio	22%
Assets	$11.91B
Total Debt	$3.36B
Cash	$1.47B
Shares Outstanding	283.93M
EV	31.75B
Earnings Score	83%
Moat Score	95%
Safety Score	82%
Final Score	86%
Working Capital	2.24B
Current Ratio	2.2
Gross Profit	$3.53B
Shares Growth 3y	-2%
Equity Growth QoQ	2%
Equity Growth YoY	-3%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

SEC Filings

Direct access to Agilent Technologies, Inc. (A) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2025
- 10-Q Jan 31
2024
- 10-K Oct 31
- 10-Q Jul 31
- 10-Q Apr 30
- 10-Q Jan 31
2023
- 10-K Oct 31
- 10-Q Jul 31
- 10-Q Apr 30
- 10-Q Jan 31

Sector Comparison

How does Agilent Technologies, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Agilent Technologies, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 17%

Stability 56%

loading chart...

Agilent Technologies, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Agilent Technologies, Inc..

Years

Calculation mode

= $27B

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$1.3B	$1.4B	$1.6B	$1.8B	$2B	$2.2B	$2.4B	$2.6B	$2.9B	$3.2B	$3.6B	$36B
DCF		$1.3B	$1.3B	$1.3B	$1.3B	$1.3B	$1.3B	$1.4B	$1.4B	$1.4B	$1.4B	$14B
Value	$27B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	10/2015	10/2016	10/2017	10/2018	10/2019	10/2020	10/2021	10/2022	10/2023	10/2024	TTM
Net Margins	10%	11%	15%	6%	21%	13%	19%	18%	18%	20%	19%
ROA	-	11%	12%	12%	11%	10%	13%	15%	13%	13%	13%
ROE	-	11%	14%	7%	23%	15%	22%	24%	21%	22%	21%

Good Net Margins (18.92%)

Net Margins are high enough to offer a good protection on the profits in case of higher costs or higher interests. Furthermore higher margins reduce earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	10/2015	10/2016	10/2017	10/2018	10/2019	10/2020	10/2021	10/2022	10/2023	10/2024	TTM
Debt over FCF	-	2.92	2.82	1.98	2.78	2.94	2.1	2.71	1.86	2.47	2.56
Debt over Equity	0.4	0.45	0.42	0.39	0.51	0.48	0.51	0.52	0.47	0.57	0.56
Growth Stability	-	-	-	61%	100%	100%	100%	100%	100%	100%	61%

Neutral Debt/FCF ratio (2.56)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Good Debt/Equity ratio (0.56)

The company is not overleveraged and has a good balance between equity and debt.

Bad Graham’s Stability (61%)

The company has a bad stability in its earnings, which is a sign of a bad competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	10/2015	10/2016	10/2017	10/2018	10/2019	10/2020	10/2021	10/2022	10/2023	10/2024	CAGR 5Y
Revenue YoY growth	-	4%	6%	10%	5%	3%	18%	8%	-0%	-5%	5%
Earnings YoY growth	-	15%	48%	-54%	239%	-33%	68%	4%	-1%	4%	14%
Equity YoY growth	-	2%	14%	-5%	4%	3%	11%	-2%	10%	1%	6%
FCF YoY growth	-	66%	9%	28%	-5%	-7%	62%	-21%	44%	-7%	13%